1st Quarter - Report
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
$80,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R.5376: Build Back Better Act including H.R.3: Elijah E. Cummings Lower Drug Costs Now Act, and H.R.19. Lower Costs, More Cures Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Reauthorization of the Prescription Drug User Fee Act and related issues. H.R.2471: Consolidated Appropriations Act, 2022. H.R.7007: COVID Supplemental Appropriations Act, 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.